Hackensack Meridian Health
Hackensack Meridian Health operates a comprehensive and integrated healthcare network in New Jersey, dedicated to providing a complete range of medical services and innovative care. The organization focuses on enhancing preventative care, managing chronic conditions, and maintaining financial viability in a value-based environment. Their offerings include ambulatory care centers, surgery centers, home health services, long-term care, assisted living, ambulance services, air medical transportation, rehabilitation, urgent care, and wellness programs. With a commitment to family and patient-centered care, Hackensack Meridian Health emphasizes world-class education and research, aiming to better serve the health needs of communities across New Jersey.
FluidForm is a provider of 3D bioprinting services to build the additive manufacturing platform for 3D printing silicone and 3D bioprinting. The company's FRESH technology enables the printing of silicones, urethanes, epoxies, liquid metals, biologic materials, and more, revolutionizing diverse fields, from aerospace to wearable sensors to regenerative medicine. FluidForm was founded in 2018 and is headquartered in, Acton, MA.
Private Equity Round in 2021
Med-Metrix specializes in performance management and revenue cycle solutions for the healthcare sector. The company offers a comprehensive suite of services, including patient intake, revenue integrity, collections, and business insights, all designed to enhance the productivity and financial margins of healthcare providers. Utilizing its proprietary FLOWtechnology platform, Med-Metrix delivers graphic-rich reporting and automated workflows, which can be complemented by advisory and outsourcing services as necessary. This integrated approach aims to improve both the patient experience and revenue collections for hospitals and healthcare systems.
EpiBone, Inc. is a biotechnology company based in Brooklyn, New York, founded in 2013, that focuses on developing innovative solutions for bone reconstruction. The company employs advanced technology to create defect-specific living bone grafts by utilizing scans of a patient’s bone defect along with their own stem cells. This process involves cultivating the graft in a custom bioreactor, allowing the new bone to grow in a controlled environment. EpiBone's approach aims to deliver precise repair of bone defects, streamline surgical procedures, enhance bone formation and regeneration, and reduce recovery times. This technology presents a significant advancement for the over 900,000 patients who undergo bone-related surgeries annually, eliminating the complications typically associated with foreign body implants.
Englewood Health is a prominent healthcare network in New Jersey, offering a range of medical services through its hospital and associated facilities. It operates as a subsidiary of Hackensack Meridian Health, providing specialized care in various medical fields, including physical medicine and surgery. Englewood Health is dedicated to delivering high-quality healthcare to its community, focusing on patient-centered services and comprehensive treatment options. Through its commitment to excellence in medical care, it plays a vital role in the region's healthcare landscape.
Pillo, Inc. designs and develops a digital care management platform that provides health care plans for adults with chronic conditions at home. The company offers Pillo, a robot, which enable people to manage their health; answer health and wellness questions; connect with healthcare professionals; manage vitamins and medication; and store, dispense, and order refills when required. The company’s robot also sends notifications to the user when medications are missed; sees and hears user to keep them healthy and safe; and syncs with wearables and smart home devices. Pillo, Inc. was incorporated in 2015 and is based in New York, New York.
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.